Comparable stake leader
Cormorant Asset Management, LP
SEC ownership of EyePoint, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001314102.
Disclosed value leader
Cormorant Asset Management, LP
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Symbol
- EYPT on Nasdaq
- Ownership evidence mix
- 3/4/5, 13D/G, and 13F
- Largest current holder
- Cormorant Asset Management, LP
- Latest large-stake holder
- Cormorant Asset Management, LP
- Latest evidence date
- 31 Mar 2026
- CIK
- 0001314102
- Location
- Watertown, MA
Ownership snapshot
2 signals
Issuer identity
2 identity fields
Ownership snapshot
Top shareholders of EyePoint, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cormorant Asset Managemen...
Disclosed value leader
Cormorant Asset Managemen...
Comparable rows
50/50
Latest evidence
31 Mar 2026
3/4/5
13D/G
13F
Lead comparable stake: 10%
13D/G row: Cormorant Asset Management, LP
Showing 1-8 of 50 holder rows.
Quick read
Cormorant Asset Management, LP leads the comparable SEC ownership view at 10%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Cormorant Asset Management, LP
10%
FEDERATED HERMES, INC.
6.7%
BlackRock, Inc.
6.5%
FRANKLIN RESOURCES INC
6.1%
RA CAPITAL MANAGEMENT, L.P.
4.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
3/4/5
13D/G
13F
Former 10% Owner · Company
|
10%
from 13D/G
|
$129,793,560
8,265,000 shares
|
-$942,240 | 04 Dec 2025 |
| FEDERATED HERMES, INC. |
13F
13D/G
Company
|
6.7%
from 13D/G
|
$73,081,003
5,669,589 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$92,515,874
7,177,337 shares
|
— | 31 Mar 2026 |
| FRANKLIN RESOURCES INC |
13F
13D/G
Company
|
6.1%
from 13D/G
|
$65,076,424
5,048,598 shares
|
— | 31 Mar 2026 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
4.7%
|
$20,809,090
3,181,818 shares
|
$0 | 31 Dec 2024 |
| TCG Crossover GP II, LLC |
13D/G
|
4.3%
|
$62,265,799
3,572,335 shares
|
$0 | 31 Dec 2025 |
| Adage Capital Management, L.P. |
13D/G
3/4/5
10%+ Owner
|
4%
|
$46,827,000
3,300,000 shares
|
-$19,866,000 | 31 Mar 2026 |
| Paradigm Biocapital Advisors LP |
13D/G
13F
Company
|
3.8%
|
$44,591,181
3,142,437 shares
|
-$14,897,003 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$1,949,062.
Buys
$19,724
Insiders: 1
Sells
$1,968,786
Insiders: 3
Net
-$1,949,062
Shares: -121,078
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 1,500
Shares: 122,578
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 1,500 | 4,875 | $19,724 | $80,127 | -$60,403 |
| 3-6 | 0 | 114,281 | $0 | $1,846,592 | -$1,846,592 |
| 6-9 | 0 | 3,422 | $0 | $42,067 | -$42,067 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 22 reporting-owner rows connected to EyePoint, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
22
Largest current holder
Cormorant Asset Management, LP
Net 12M change
-$1,949,062
Latest report
25 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | Former 10% Owner | $129,793,560 | -$942,240 | -0.72% | Filing P/S | 04 Dec 2025 |
| EW Healthcare Partners, L.P. | Other*, 10%+ Owner | $87,327,483 | Mixed | 01 Sep 2023 | ||
| Nancy Lurker | Director | $7,696,047 | -$150,942 | -1.9% | Mixed | 06 Jan 2026 |
| Jay S. Duker | President and CEO, Director | $3,259,678 | +$19,724 | +0.61% | Mixed | 23 Mar 2026 |
| Therapeutics Ocumension | Director | $2,507,088 | Mixed | 11 Jan 2024 | ||
| Ye Liu | Director | $2,507,088 | Mixed | 11 Jan 2024 | ||
| George Elston | Chief Financial Officer | $1,568,596 | Median | 25 May 2026 | ||
| David Scott Jones | SVP & Chief Commercial Officer | $1,437,581 | Mixed | 09 Feb 2024 | ||
| Dario A. Paggiarino | Chief Medical Officer | $1,386,544 | Mixed | 30 Mar 2024 | ||
| Michael Craig Pine | Chief Corp Dev.&Strat. Officer | $965,391 | Mixed | 05 Jan 2024 | ||
| Ramiro Ribeiro | Chief Medical Officer | $512,120 | -$875,604 | -63% | Mixed | 17 Apr 2026 |
| Karen L. Zaderej | Director | $382,875 | Mixed | 02 Jan 2026 | ||
| Douglas Evan Godshall | Director | $200,525 | Mixed | 22 Jun 2021 | ||
| John B. Landis | Director | $185,752 | Mixed | 02 Jan 2026 | ||
| Anthony P. Adamis | Director | $61,783 | Mixed | 23 Jun 2024 | ||
| David R. Guyer | Director | $18,619 | Filing P/S | 12 Jul 2024 | ||
| Fred Hassan | Director | Mixed | 02 Jan 2026 | |||
| Wendy F. Dicicco | Director | Mixed | 02 Jan 2026 | |||
| Stuart Duty | Director | Mixed | 02 Jan 2026 | |||
| Goran Ando | Director | Mixed | 02 Jan 2026 |
Recent insider transactions for EyePoint, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| George Elston | EYPT | Common Stock | Tax liability | -3.81% | -3,627 | 91,691 | 25 May 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Options Exercise | 8.54% | 7,500 | 95,318 | 25 May 2026 | Direct | ||
| George Elston | EYPT | Restricted Stock Units | Options Exercise | -100% | -7,500 | 0 | 25 May 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Common Stock | Sale | -100% | $36,555 | $15.00 | -2,437 | 0 | 17 Apr 2026 | Direct |
| Ramiro Ribeiro | EYPT | Common Stock | Options Exercise | 2,437 | 2,437 | 17 Apr 2026 | Direct | |||
| Ramiro Ribeiro | EYPT | Stock Option (Right to Buy) | Options Exercise | -2.94% | -2,437 | 80,438 | 17 Apr 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Other | 76.3% | 76,766 | 177,431 | 23 Mar 2026 | By Family Trust | ||
| Jay S. Duker | EYPT | Common Stock | Other | -98.7% | -76,766 | 986 | 23 Mar 2026 | Direct | ||
| Jay S. Duker | EYPT | Stock Option (Right to Buy) | Other | 150,000 | 97,500 | 23 Mar 2026 | By Family Trust | |||
| Jay S. Duker | EYPT | Stock Option (Right to Buy) | Other | -95.1% | -150,000 | 7,800 | 23 Mar 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Purchase | 1.51% | $19,724 | $13.15 | 1,500 | 100,665 | 16 Mar 2026 | By Family Trust |
| Ramiro Ribeiro | EYPT | Common Stock | Sale | -100% | $43,572 | $17.87 | -2,438 | 0 | 04 Mar 2026 | Direct |
| Ramiro Ribeiro | EYPT | Common Stock | Options Exercise | 2,438 | 2,438 | 04 Mar 2026 | Direct | |||
| Ramiro Ribeiro | EYPT | Stock Option (Right to Buy) | Options Exercise | -2.86% | -2,438 | 82,875 | 04 Mar 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Gift | 20% | 5,000 | 30,000 | 02 Mar 2026 | By Family Trust | ||
| George Elston | EYPT | Common Stock | Gift | -5.39% | -5,000 | 87,818 | 02 Mar 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Common Stock | Sale | -100% | $36,555 | $15.00 | -2,437 | 0 | 17 Feb 2026 | Direct |
| Ramiro Ribeiro | EYPT | Common Stock | Options Exercise | 2,437 | 2,437 | 17 Feb 2026 | Direct | |||
| Ramiro Ribeiro | EYPT | Stock Option (Right to Buy) | Options Exercise | -2.78% | -2,437 | 85,313 | 17 Feb 2026 | Direct | ||
| Nancy Lurker | EYPT | Common Stock | Options Exercise | 34.3% | 75,133 | 294,346 | 06 Jan 2026 | Direct | ||
| Nancy Lurker | EYPT | Restricted Stock Units | Options Exercise | -100% | -75,133 | 0 | 06 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Tax liability | -11.4% | -10,054 | 77,752 | 06 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Options Exercise | 31% | 20,793 | 87,806 | 06 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Restricted Stock Units | Options Exercise | -100% | -20,793 | 0 | 06 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Tax liability | -4.66% | -4,487 | 91,852 | 06 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Options Exercise | 18.9% | 15,285 | 96,339 | 06 Jan 2026 | Direct | ||
| George Elston | EYPT | Restricted Stock Units | Options Exercise | -100% | -15,285 | 0 | 06 Jan 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Common Stock | Sale | -100% | $727,319 | $17.10 | -42,544 | 0 | 05 Jan 2026 | Direct |
| Ramiro Ribeiro | EYPT | Common Stock | Options Exercise | 220% | 29,250 | 42,544 | 05 Jan 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Stock Option (Right to Buy) | Options Exercise | -25% | -29,250 | 87,750 | 05 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Tax liability | -17.8% | -14,505 | 67,013 | 05 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Options Exercise | 58.2% | 30,000 | 81,518 | 05 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Restricted Stock Units | Options Exercise | -50% | -30,000 | 30,000 | 05 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Tax liability | -5.15% | -4,403 | 81,054 | 05 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Options Exercise | 21.3% | 15,000 | 85,457 | 05 Jan 2026 | Direct | ||
| George Elston | EYPT | Restricted Stock Units | Options Exercise | -50% | -15,000 | 15,000 | 05 Jan 2026 | Direct | ||
| Nancy Lurker | EYPT | Common Stock | Options Exercise | 6.13% | 12,666 | 219,213 | 05 Jan 2026 | Direct | ||
| Nancy Lurker | EYPT | Restricted Stock Units | Options Exercise | -50% | -12,666 | 12,667 | 05 Jan 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Common Stock | Tax liability | -32.4% | -6,373 | 13,294 | 03 Jan 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Common Stock | Options Exercise | 19,667 | 19,667 | 03 Jan 2026 | Direct | |||
| Ramiro Ribeiro | EYPT | Restricted Stock Units | Options Exercise | -33.3% | -19,667 | 39,333 | 03 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Tax liability | -31.3% | -23,447 | 51,518 | 03 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Options Exercise | 652.3% | 65,000 | 74,965 | 03 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Restricted Stock Units | Options Exercise | -33.3% | -65,000 | 130,000 | 03 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Tax liability | -8.24% | -6,324 | 70,457 | 03 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Options Exercise | 34.4% | 19,667 | 76,781 | 03 Jan 2026 | Direct | ||
| George Elston | EYPT | Restricted Stock Units | Options Exercise | -33.3% | -19,667 | 39,333 | 03 Jan 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Stock Option (Right to Buy) | Award | 171,400 | 171,400 | 02 Jan 2026 | Direct | |||
| Ramiro Ribeiro | EYPT | Restricted Stock Units | Award | 85,700 | 85,700 | 02 Jan 2026 | Direct | |||
| Jay S. Duker | EYPT | Stock Option (Right to Buy) | Award | 331,000 | 331,000 | 02 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.